515 completed. 515 Phase 2, 91 Phase 1, 73 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 515 | Completed 515 |
| Phase 1 | 91 | Completed 91 |
| Phase 3 | 73 | Completed 73 |
Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney Disease Human Wharton's jelly mesenchymal stem cell (HWJ-MSC) exosomes, Human umbilical vein endothelial cell (HUVEC) exosomes, Placebo (0.9% sodium chloride) - Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4 | Phase 1 / Phase 2 | Completed | Nurhasan Agung Prabowo | 34 | 2026-07-01 | 2026-11-06 |
| Chemical vs Mechanical Pleural Adhesiolysis for Liberation of Captive Pleura in Stacked Effusion Intrapleural Hydrogen Peroxide (H_2O_2), Intrapleural Corticosteroids, Thoracoscopic Mechanical Pleurolysis - Pleural Infection, Pleural Adhesions | Phase 2 | Completed | Delta University for Science and Technology | 36 | 2026-03-26 | 2026-07-20 |
| Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients, Neuroinflammation | Phase 2 | Completed | Hasanuddin University | 80 | 2025-10-01 | 2026-05-12 |
| Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases GcMAF, Placebo Injection (Saline) - Inflammation | Phase 1 / Phase 2 | Completed | S.LAB (SOLOWAYS) | 120 | 2025-09-01 | 2025-12-16 |
| N-Acetylcysteine in Patients With Leptospirosis N-acetylcysteine, Placebo - Leptospirosis | Phase 2 | Completed | Dr Cipto Mangunkusumo General Hospital | 64 | 2025-08-30 | 2026-09-16 |
| Effects of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, and Clinical Outcomes in Patients With Pneumonia and Sepsis Placebo Tablet(s), DLBS1033 - Pneumonia, Sepsis | Phase 2 | Completed | Universitas Sebelas Maret | 50 | 2025-08-14 | 2026-10-23 |
| A Study of NTRX-07 in Participants With Alzheimer's Disease NTRX-07, Placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Completed | NeuroTherapia, Inc. | 48 | 2025-03-01 | 2026-10-29 |
| A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients EI-1071 tablet, oral - Mild, Moderate, or Severe Alzheimer's Disease | Phase 2 | Completed | Elixiron Immunotherapeutics Inc. | 7 | 2024-12-16 | 2026-09-23 |
| Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia Structured Supportive Psychotherapy, Risperidone 2 mg - Schizophrenia, Cognitive Dysfunction | Phase 2 | Completed | Hasanuddin University | 46 | 2024-12-01 | 2026-03-17 |
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
| Effect of Bee Venom on T Regulatory Cells and Inflammation in Hemodialysis Patients: a Prospective Study Thesis Bee Venom (BV) - Hemodialysis, Inflammation | Phase 1 / Phase 2 | Completed | Mansoura University | 60 | 2024-06-01 | 2026-10-30 |
| The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock Norepinephrine, Ringer's Lactate - Septic Shock, Sepsis | Phase 2 / Phase 3 | Completed | Universitas Indonesia | 42 | 2024-03-25 | 2024-06-20 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants Cefiderocol, Standard of Care - Gram-Negative Bacterial Infections | Phase 2 | Completed | Shionogi | 30 | 2024-03-14 | 2026-03-02 |
| Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction HT-6184, HT-6184 Placebo - Pain | Phase 2 | Completed | Halia Therapeutics, Inc. | 81 | 2024-02-12 | 2025-03-30 |
| Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) TIN816 70 mg lyophilisate powder, Placebo - Acute Kidney Injury Due to Sepsis | Phase 2 | Completed | Novartis Pharmaceuticals | 316 | 2024-01-18 | 2026-07-29 |
| Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery VVN461 Ophthalmic Solution 1.0%, VVN461 Ophthalmic Solution 0.5%, Vehicle - Inflammation | Phase 2 | Completed | VivaVision Biotech, Inc | 91 | 2024-01-11 | 2026-09-11 |
| Polyamine Treatment in Elderly Patients With Coronary Artery Disease Spermidine, Placebo - Ischemic Heart Disease, Myocardial Infarction | Phase 2 | Completed | University of Aarhus | 187 | 2024-01-01 | 2026-07-01 |
| Multimodal Vasopressor Strategy in Septic Shock Simultaneous administration of vasopressors, Successive administration of vasopressors - Shock, Septic | Phase 2 / Phase 3 | Completed | University Medical Centre Maribor | 79 | 2023-12-23 | 2026-03-31 |
| Single and Multiple Ascending Oral Doses of Avenanthramide Avenanthramide, Placebo - Inflammation | Phase 1 / Phase 2 | Completed | Montreal Heart Institute | 92 | 2023-12-09 | 2026-04-20 |
| A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage Ir-CPI - Intracerebral Hemorrhage | Phase 2 | Completed | Bioxodes S.A. | 23 | 2023-11-17 | 2026-07-23 |
Showing 20 of 515. Sign in to see all of them.
Sepsis (116) · Shock, Septic (84) · Cellulitis (19) · Cytokine Release Syndrome (18) · Pain (18) · COVID-19 (16) · Cardiovascular Diseases (14) · Abscess (12) · Atherosclerosis (12) · Bacteremia (12) · Metabolic Syndrome (12) · Neuroinflammatory Diseases (12) · Systemic Inflammatory Response Syndrome (12) · Diabetes Mellitus, Type 2 (11)
Pathological Conditions, Signs and Symptoms (515) · Pathologic Processes (513) · Infections (236) · Systemic Inflammatory Response Syndrome (195) · Shock (110) · Respiratory Tract Diseases (68) · Sepsis (67) · Cardiovascular Diseases (65) · Signs and Symptoms (61) · Immune System Diseases (58) · Lung Diseases (56) · Vascular Diseases (55) · Skin and Connective Tissue Diseases (51) · Urogenital Diseases (51)
Saline Solution (16) · Sodium Chloride (16) · Ascorbic Acid (13) · Standard of Care (11) · Interleukin 1 Receptor Antagonist Protein (9) · salicylsalicylic acid (9) · Thiamine (7) · Daptomycin (6) · Fish Oils (6) · Glucose (6) · Aspirin (5) · Hydrocortisone (5) · Ibuprofen (5) · Metformin (5) · Norepinephrine (5)
Beth Israel Deaconess Medical Center (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Virginia Commonwealth University (7) · GlaxoSmithKline (6) · Novartis Pharmaceuticals (6) · Novo Nordisk A/S (6) · University of Florida (6) · University of Roma La Sapienza (6) · Vanderbilt University (6) · AstraZeneca (5) · Radboud University Medical Center (5) · Ain Shams University (4) · Charite University, Berlin, Germany (4) · Joslin Diabetes Center (4) · National Eye Institute (NEI) (4)
United States (251) · Canada (40) · Germany (35) · Spain (31) · France (30) · Italy (26) · Netherlands (25) · United Kingdom (25) · Belgium (22) · Denmark (20) · Australia (16) · Poland (16) · Brazil (15) · Egypt (15) · Hungary (13)
Andrea Morelli, MD (5) · Allison B. Goldfine, MD (4) · Antonio Abbate, MD, PhD (3) · Benjamin Van Tassell, PharmD (3) · Eric Bellissant, MD, PhD (3) · Issam Raad, MD (3) · Michael W Donnino, MD (3) · Wayne Dankner, MD (3) · Yoghatama Cindya Zanzer, MSc (3) · Andrea Morelli, M.D. (2)
PMID 23001587, PMID 28159728, PMID 37916745, PMID 38321529, PMID 39230271, PMID 10379020, PMID 14987884, PMID 15713907, PMID 16003060, PMID 16505648, PMID 16507156, PMID 16636217, PMID 16980879, PMID 17076839, PMID 17206944, PMID 17429083, PMID 17551901, PMID 17558345, PMID 17617901, PMID 17636753, PMID 17660031, PMID 17715164, PMID 17720019, PMID 17825587, PMID 17896838, PMID 17950857, PMID 17959861, PMID 18413833, PMID 18668591, PMID 18674932, PMID 19017409, PMID 19048243, PMID 19114895, PMID 19114908, PMID 19172247, PMID 19196814, PMID 19220646, PMID 19454532, PMID 19590022, PMID 19664253, PMID 19733615, PMID 19797553, PMID 19944358, PMID 20231565, PMID 20441419, PMID 20520776, PMID 20597663, PMID 20613460, PMID 20634018, PMID 20689074
2017 (4), 2015 (3), 2019 (3), 2009 (2), R01HL095149 (2), U01DK074556 (2), U01HD019897 (2), U10HD021364 (2), U10HD021373 (2), U10HD021385 (2), U10HD021397 (2), U10HD021415 (2), 1KL2RR031989-01 (1), 1RF1AG051514 (1), 1UM1HL116885-01 (1)